Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy-Reference-Cited by-同舟云学术

Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy

Published:2019-06 Issue:11 Volume:27 Page:3315-3330.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Celis-Gutierrez Javier,Blattmann Peter,Zhai Yunhao,Jarmuzynski Nicolas,Ruminski Kilian,Grégoire Claude,Ounoughene Youcef,Fiore Frédéric,Aebersold Ruedi,Roncagalli Romain,Gstaiger Matthias,Malissen Bernard

Funder

Agence Nationale de la Recherche

European Research Council

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. CD4(+) T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness;Ahrends;Immunity,2017

2. Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization;Baitsch;PLoS ONE,2012

3. Crispr/Cas mediated deletion of PTPN22 in Jurkat T cells enhances TCR signaling and production of IL-2;Bray;Front. Immunol.,2018

4. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies;Bunnell;J. Cell Biol.,2002

5. In vitro reconstitution of T cell receptor-mediated segregation of the CD45 phosphatase;Carbone;Proc. Natl. Acad. Sci. U S A,2017

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event;Cancers;2024-07-24

2. Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes;OncoImmunology;2024-07-08

3. BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes;iScience;2024-07

4. PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation;Blood Advances;2024-06-03

5. Polymer-based antibody mimetics (iBodies) target human PD-L1 and function as a potent immune checkpoint blocker;Journal of Biological Chemistry;2024-06